Fig. 2From: Cytokeratin 20 positive circulating tumor cells are a marker for response after neoadjuvant chemoradiation but not for prognosis in patients with rectal cancerIn the group of patients receiving neoadjuvant chemoradiation (n = 79) the overall survival of responders is significantly better compared to non-respondersBack to article page